MeSH Browser

MeSH Supplementary: ofatumumab
Unique ID: C527517
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C527517
Entry Term(s): GSK-1841157; GSKI841157; HUMAX-CD20 2F2; HUMAX-CD20, 2F2; HUMAX-CD20-2F2; arzerra; kesimpta
Pharm Action: Antineoplastic Agents
Registry Numbers: M95KG522R0; 0
Heading Mapped to: *Antibodies, Monoclonal, Humanized
Frequency: 383
Note: an anti-CD20 MAb used as an antineoplastic agent; in phase 1-2 clinical trials
Source: Blood 2008 Feb 1;111(3):1094-100
Indexing Information: Antigens, CD20
Date of Entry: 2008/03/24
Revision Date: 2021/08/18

ofatumumab MeSH Supplementary Concept Data 2025